Imperial is participating in Jisc’s “Read and Publish” pilot with Wolters Kluwer from January 2022 until the end of December 2024.
The agreement provides open access publishing for Corresponding Authors in the Total Access Collection of over 300 medical and nursing journals published by Lippincott Williams & Wilkins (LWW) including many society-owned journals at no further charge to the author. This agreement also includes unlimited read access to those journals.
To be eligible, articles must:
- Be a peer reviewed research article, review or conference paper.
- Be accepted for publication on or after 1st January 2022.
- Have a corresponding author affiliated with a participating institution.
All accepted research papers meeting the requirements above will automatically be considered for open access publication under this agreement via Copyright Clearance Centre. Please use your Imperial affiliation and email address when you submit to ensure that you are identified as eligible.
Please note, this agreement covers hybrid journals only and fully open access journals are excluded. The Journal of the American College of Surgeons and titles within the JCO bundle are also excluded from this Agreement - see table below. Non hybrid (read only) titles, that do not offer OA publishing, plus backfile only titles are also excluded. New titles may be added throughout the lifecycle of the agreement.
Product code | Description | ISSN |
---|---|---|
JACS-JN-N21 | Journal of the American College of Surgeons | 1072-7515 |
JCCI-JN-N20 | JCO Clinical Cancer Informatics | 2473-4276 |
JGLO-JN-OA | JCO Global Oncology | 2687-8941 |
JOCO-JN-N20 | Journal of Clinical Oncology | 0732-183X |
JONP-JN-N20 |
JCO Oncology Practice | 2688-1527 |
JOPO-JN-N20 | JCO Precision Oncology |
2473-4284 |
Journals included in this agreement and others we have signed can be found using our journal search tool using journal title, ISSN or keyword.
If you have any questions regarding this agreement or the process please contact the open access team.